Persistent human papillomavirus infection is the central cause of cervical cancer, the leading
cause of cancer death among women worldwide. Clear evidence from both randomized …

Background: Human papillomavirus (HPV) is now known to be a necessary cause of
cervical cancer, and prophylactic HPV vaccines aimed at preventing genital warts …

Human papillomavirus (HPV) is the causative agent in cervical cancer and has been
implicated in a range of other malignancies. Preventative vaccines are now internationally …

Background High-risk human papillomavirus causes cervical cancer. Vaccines have been
developed that significantly reduce the incidence of preinvasive and invasive disease. This …

Human papillomavirus (HPV) vaccines for the prevention of cervical cancer have produced
encouraging results in recent clinical trials, and expectations are high that one or more …

Genital infection with human papillomaviruses (HPV) is one of the most common sexually
transmitted conditions. The central causal role in cervical carcinogenesis of the so-called …

Two very effective prevention strategies for cervical cancer exist–vaccination against the
human papillomavirus (HPV) and cervical screening with primary HPV testing followed by …

Aim Prophylactic human papillomavirus (HPV) vaccines are highly effective at preventing
pre–cancerous cervical lesions when given in a three–dose schedule. Some post–hoc trial …

Prophylactic vaccination against high risk human papilloma virus (HPV) 16 and 18
represents an exciting means of protection against HPV related malignancy. However, this …

Abstract The Human Papillomavirus Prevention and Control Board brought together experts
to discuss optimizing HPV vaccination and screening programs. Board members reviewed …